Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis II: Clinical Features of Infective Endocarditis

Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...

Rheumatic Heart Disease I: Introduction

Rheumatic Heart Disease I: Introduction

Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome I : Introduction

Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of fluid...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic ulcer disease develops when protective mechanisms of the gastrointestinal mucosa are overwhelmed by harmful factors, leading to localized erosions in the stomach or proximal duodenum. The main causes are Helicobacter pylori infection and chronic use of nonsteroidal anti-inflammatory drugs (NSAIDs).Helicobacter pylori–Induced InjuryBacterial Adaptation and Colonization:H. pylori is a spiral, Gram-negative bacterium adapted to the acidic stomach. and transmitted through oral-oral or...

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.

Hypersensitivity Reactions: Immune-Complex Reactions

Hypersensitivity Reactions: Immune-Complex Reactions

Type III hypersensitivity reactions occur when antigen–antibody complexes form and activate the complement system. Normally, these complexes help the clearance of antigens by phagocytes and red blood cells. However, when large numbers of immune complexes are present, they can deposit in tissues—particularly in the walls of blood vessels—leading to inflammation and tissue injury. These deposits trigger complement activation and neutrophil recruitment, resulting in serum sickness, a systemic...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Identifying distinct clinical phenotypes and outcomes in adult-onset IgA vasculitis using unsupervised clustering analysis.

European journal of internal medicine·2026

Same author

A Pathway to High Quality Clinical Trials in IgA Vasculitis Nephritis: Meeting Proceedings From a Multiprofessional International Collaborative Workshop.

Kidney international reports·2026

Same author

Clinicopathological Spectrum and Treatment Outcomes of Cryofibrinogen-Associated Nephropathies.

Kidney international reports·2026

Same author

Treatment strategies and outcomes in adult relapsing or refractory cutaneous IgA Vasculitis: A multicenter retrospective cohort study.

Seminars in arthritis and rheumatism·2025

Same author

Cost-utility analysis of a web-based interactive patient education platform: evidence from a randomized clinical trial for end-stage renal disease patients.

The European journal of health economics : HEPAC : health economics in prevention and care·2025

Same author

Prevalence of kidney complications in a large cohort of patients with recessive dystrophic epidermolysis bullosa.

The British journal of dermatology·2025

Search research articles

Related Experiment Video

Updated: Jul 4, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

[Henoch-Schönlein purpura].

Evangéline Pillebout¹, Patrick Niaudet

¹Service de néphrologie et de transplantation, hôpital Saint-Louis, Paris. evangeline.pillebout@sls.aphp.fr

La Revue Du Praticien

|June 6, 2008

Summary

This summary is machine-generated.

Henoch-Schönlein purpura (HSP) is an IgA vasculitis impacting small vessels, primarily affecting children. While often self-limiting, severe cases, especially in adults, can lead to significant kidney damage and end-stage renal failure.

More Related Videos

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Related Experiment Videos

Last Updated: Jul 4, 2026

Granulocyte-dependent Autoantibody-induced Skin Blistering

Granulocyte-dependent Autoantibody-induced Skin Blistering

Published on: October 12, 2012

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Humanized Mouse Model to Study Bacterial Infections Targeting the Microvasculature

Published on: April 1, 2014

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis

Published on: June 18, 2020

Area of Science:

Immunology
Rheumatology
Nephrology

Background:

Henoch-Schönlein purpura (HSP) is a systemic IgA vasculitis affecting small blood vessels.
Key manifestations include skin purpura, arthritis, gastrointestinal issues, and potential nephritis with IgA deposits.
While common in children, HSP is rarer and more severe in adults, often presenting with significant nephritis.

Purpose of the Study:

To review the immunopathogenesis, clinical features, and prognosis of Henoch-Schönlein purpura.
To highlight the role of IgA in HSP.
To discuss treatment strategies for HSP, particularly severe nephritis.

Main Methods:

Literature review of Henoch-Schönlein purpura.
Analysis of clinical features and immunopathogenesis.
Evaluation of short-term and long-term outcomes, including renal involvement.

Main Results:

IgA plays a central role in the immunopathogenesis of HSP.
Prognosis is dictated by the severity of gastrointestinal symptoms and nephritis.
Up to one-third of patients may progress to end-stage renal failure.

Conclusions:

Symptomatic treatment is recommended for self-limited HSP.
Management of severe HSP nephritis remains debated, with potential benefits from corticosteroids and immunosuppressants requiring further confirmation.